Home > Rheumatology > EULAR 2018 > Ankylosing Spondylitis > Synergistic Effect NSAIDs plus TNFi in Slowing Radiographic Progression in Ankylosing Spondylitis Patients

Synergistic Effect NSAIDs plus TNFi in Slowing Radiographic Progression in Ankylosing Spondylitis Patients

Presented By
Dr Gensler, University of California San Francisco Medical Center, US
Conference
EULAR 2018
Trial
Cohort study, PSOAS

Dose-related use of NSAIDs together with TNFi in AS patients has a synergistic effect in slowing radiographic progression. The greatest effect is seen in those using both high-dose NSAIDs and TNFi. Of all NSAIDs, celecoxib appears to confer the greatest benefit in decreasing progression with effect at both 2 and 4 years. According to Dr Gensler (University of California San Francisco Medical Center, US), the potential of TNFi and/or NSAIDs to reduce radiographic progression in AS was uncertain.

Until now, causal effects of both exposures on radiographic progression have not been convincingly demonstrated. In addition, no study has evaluated whether effects are comparable among different NSAIDs in this setting. Therefore, Gensler et al. explored the causal effects of TNFi on radiographic progression in AS and determined whether the NSAID dose and type impact this relationship.

A total of 519 adult patients from the Prospective Study of Outcomes in Ankylosing Spondyli...



please login to read the entire article:


You need to register to read the entire article, please do so now.





Posted on